Transcutaneous electrical nerve stimulation
Transcutaneous Electrical Nerve Stimulation (TENS) may support liver health indirectly, primarily through neuro-modulatory, anti-inflammatory, autonomic, and symptom-relief mechanisms. Like other neuromodulatory therapies, its value lies in modifying upstream drivers of liver injury rather than directly treating liver pathology.
Prolotherapy
Prolotherapy can potentially have an indirect and supportive effect, primarily through pain reduction and functional improvement that may secondarily influence lifestyle factors relevant to liver disease.
Trigger point injections
Trigger point injections (TPIs) have no direct therapeutic effect on liver health. Any relevance to liver health is indirect and supportive, similar to prolotherapy, and limited to how pain control can influence lifestyle and medication use.
